Cargando…
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
BACKGROUND/AIM: The role of humoral immunity in hepatitis C virus (HCV) infection is poorly understood. Nevertheless, there is increasing interest in characterizing the neutralizing antibodies in the serum of HCV-infected patients. Focus reduction assays have been widely used to evaluate neutralizin...
Autores principales: | Fournier, Carole, Duverlie, Gilles, François, Catherine, Schnuriger, Aurelie, Dedeurwaerder, Sarah, Brochot, Etienne, Capron, Dominique, Wychowski, Czeslaw, Thibault, Vincent, Castelain, Sandrine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852297/ https://www.ncbi.nlm.nih.gov/pubmed/17397531 http://dx.doi.org/10.1186/1743-422X-4-35 |
Ejemplares similares
-
Enhanced anti-HCV activity of interferon alpha 17 subtype
por: Dubois, Aurelie, et al.
Publicado: (2009) -
Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020) -
Comparison of different serological assays for SARS-CoV-2 in real life
por: Brochot, Etienne, et al.
Publicado: (2020) -
Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis
por: Aubry, Aurélien, et al.
Publicado: (2021) -
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays
por: Demey, Baptiste, et al.
Publicado: (2020)